Romiplostim is effective in boosting platelet counts in most children with chronic immune thrombocytopenia (ITP) and can lead to a treatment-free response in almost a quarter of children. A long-term extension study enrolled 66 children from previous phase 1/2 and phase 3 studies comparing romiplostim with placebo. The children were recruited from 28 sites in ...
Treatment-free response possible in ITP kids after romiplostim
By Mardi Chapman
21 Mar 2019